Literature DB >> 18593890

C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine.

Julie A Wilkins1, Owen J Sansom.   

Abstract

The Adenomatous polyposis coli (Apc) gene is mutated in up to 80% of sporadic colorectal cancers. After Apc loss, there is deregulation of the Wnt signaling pathway and transactivation of T-cell factor/leukemia enhancing factor target genes such as C-Myc. This review focuses on recent data highlighting the importance of the C-Myc oncogene and its transcriptional targets in establishing all of the phenotypes caused by the deletion of the Apc tumor suppressor gene within the intestinal epithelium. The importance of investigating Apc and C-Myc gene function in the correct tissue context is also discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18593890     DOI: 10.1158/0008-5472.CAN-07-5558

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

1.  Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.

Authors:  Manjinder Kaur; Balaiya Velmurugan; Alpna Tyagi; Chapla Agarwal; Rana P Singh; Rajesh Agarwal
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

Review 2.  c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.

Authors:  Chenguang Wang; Yanhong Tai; Michael P Lisanti; D Joshua Liao
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

Review 3.  Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting.

Authors:  William Hankey; Wendy L Frankel; Joanna Groden
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

4.  The myc 3' wnt-responsive element suppresses colonic tumorigenesis.

Authors:  Wesley M Konsavage; Gregory S Yochum
Journal:  Mol Cell Biol       Date:  2014-02-24       Impact factor: 4.272

Review 5.  Genome recognition by MYC.

Authors:  Arianna Sabò; Bruno Amati
Journal:  Cold Spring Harb Perspect Med       Date:  2014-02-01       Impact factor: 6.915

6.  Modifier-concept of colorectal carcinogenesis: lipidomics as a technical tool in pathway analysis.

Authors:  Nikolaus Gassler; Christina Klaus; Elke Kaemmerer; Andrea Reinartz
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

7.  TIKI2 suppresses growth of osteosarcoma by targeting Wnt/β-catenin pathway.

Authors:  Ruhui Li; Jianguo Liu; Hong Wu; Lidi Liu; Lijun Wang; Shaokun Zhang
Journal:  Mol Cell Biochem       Date:  2014-04-27       Impact factor: 3.396

Review 8.  The ups and downs of Myc biology.

Authors:  Laura Soucek; Gerard I Evan
Journal:  Curr Opin Genet Dev       Date:  2009-12-03       Impact factor: 5.578

9.  ERK activation drives intestinal tumorigenesis in Apc(min/+) mice.

Authors:  Sung Hee Lee; Li-Li Hu; Jose Gonzalez-Navajas; Geom Seog Seo; Carol Shen; Jonathan Brick; Scott Herdman; Nissi Varki; Maripat Corr; Jongdae Lee; Eyal Raz
Journal:  Nat Med       Date:  2010-05-09       Impact factor: 53.440

10.  Krüppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations.

Authors:  Mandayam O Nandan; Amr M Ghaleb; Beth B McConnell; Nilesh V Patel; Sylvie Robine; Vincent W Yang
Journal:  Mol Cancer       Date:  2010-03-18       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.